Copyright 2009 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2009
Commentary on: Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION)
Saurat JH, Stingl G, Dubertret L, et al
Br J Dermatol. 2008;158(3):558-566
Question: How effective and safe is adalimumab compared with methotrexate in patients with moderate to severe psoriasis?
Design: Noninferiority randomized controlled trial.
Batchelor JM, Ingram JR, Williams H. Adalimumab vs Methotrexate for the Treatment of Chronic Plaque Psoriasis. Arch Dermatol. 2009;145(6):704–706. doi:10.1001/archdermatol.2009.104
Customize your JAMA Network experience by selecting one or more topics from the list below.